<<Get Ready for More Biotech Bankruptcies >>
Does this please you, Dew?
Is it your overall thesis that there is little future in attempting to develop new therapies for disease? That it is a negative NPV venture - perhaps because remaining unmet medical needs are too complex for the current state of science?
Because between welcoming the BP megamergers, which are significantly funded by cutting combined R&D, and appearing to welcome this capital market 'proof' that most biotechs are scams, and seeming to crow every time a development program blows up, that seems to be your position.
It's a perfectly tenable position, but it would be helpful to know where you're coming from. If you've set out your thesis in the past, I'm sure you'll provide the link. TIA
News 
Market Data 
Discover 
AI
